Skip to content
healthcare.dev
Get a free key

Trilitas

NDC 87143-200, TAZAROTENE, gel, from Perfero Pharma, Inc..

Product NDC
87143-200
Status
Listed
Labeler
Perfero Pharma, Inc.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214136
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87143-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAZAROTENE1 mg/g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
87143-200-30871430200301 TUBE in 1 CARTON (87143-200-30) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1cf1faef-73b8-4ab2-a4c8-521f0bd3fc10

Use it

Look up 87143-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87143-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87143-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.